MedPath

A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting

Not Applicable
Active, not recruiting
Conditions
Attention Deficit/Hyperactivity Disorder
Registration Number
NCT04189575
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This study will assess the efficacy of the text messaging (SMS-based) disease management intervention to improve adherence to stimulants in adults with Attention Deficit/Hyperactivity Disorder (ADHD) within the Partners primary and psychiatry care settings.

Participants in the study will receive customized text messages twice a day, every day, for a duration of 9 months. The text messages will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
117
Inclusion Criteria
  • Male and female adults ages 18-55 years
  • Receipt of a prescription for stimulant medication by their primary care physician or psychiatrist
  • Proficient in English
  • Has a cellular phone with text messaging capabilities and is interested in and willing to receive free of charge planned text messages
Exclusion Criteria
  • Investigator and his/her immediate family
  • Unwilling/unable to comply with study procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Adherence to Stimulants9 months

Adherence will be analyzed using the timeliness of stimulant medication prescription renewals over the 9 month period.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath